| ∧ ∨ Type | ∧ ∨ Title | Principal Investigators | Status | ∧ ∨ Year |
|---|---|---|---|---|
| PRIN2022 - PRIN bando 2022 |
Neuromodulation for Diabetes Treatment
|
|
Ongoing | 2023 |
| PRIN2022 - PRIN bando 2022 |
Leo&Giulia talking to kids about smoking: a digital health education school-based cluster-randomized controlled trial to promote health and prevention in children
|
|
Ongoing | 2023 |
| PRIN2022 - PRIN bando 2022 |
Spinal muscular atrophy: clinical phenotypes and biomarkers at the time of the new disease modifyig therapies
|
|
Ongoing | 2023 |
| PRIN2022 - PRIN bando 2022 |
The neuromechanics of the ACL injury: implications of the loss of ligament sensory afferents on motor control and movement biomechanics in patients who underwent surgical reconstruction
|
|
Ongoing | 2023 |
| PRIN2022 - PRIN bando 2022 |
“INTERACT”- The role of proteIn foldiNg in proTozoan infEctions: unravelling the inteRACTtome of Leishmania molecular chaperones
|
|
Ongoing | 2023 |
| PRIN2022 - PRIN bando 2022 |
Repurposing of PPAR modulators: a novel STrategy to awaken T-cell IMmunity in the Elderly (PAST TIME)
|
|
Ongoing | 2023 |
| PSR_LINEA2_ / Piano di sviluppo di ricerca - Dotazioni dipartimentali - Linea 2 |
Piano di Sostegno alla Ricerca 2015-2017 - Linea 2 "Dotazione annuale per attività istituzionali" (anno 2021)
|
|
Ongoing | 2022 |
| PSR_LINEA2_ / Piano di sviluppo di ricerca - Dotazioni dipartimentali - Linea 2 |
Piano di Sostegno alla Ricerca 2015-2017 - Linea 2 "Dotazione annuale per attività istituzionali" (anno 2022)
|
|
Ongoing | 2023 |
| Progetti PNRR - Fondo per il Programma di Ricerca di Rilevante Interesse Nazionale - PRIN 2022 |
The countermeasures to the neuromuscular impairments induced by inactivity and disuse across different ages (ReActive-AGE)
|
|
Ongoing | 2023 |
| Progetti PNRR - Fondo per il Programma di Ricerca di Rilevante Interesse Nazionale - PRIN 2022 |
Exosomal non-coding RNAs as triggers of type I interferon-mediated autoimmune diseases: Aicardi Gouti�?res syndrome as a paradigm
|
|
Ongoing | 2023 |
